Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

PRE-test-STROKE [Personalizing REperfusion Therapeutic Strategies in Stroke]

IP: Joan Montaner Villalonga
Collaborators: Eva Baldrich Rubio, Rafael Simó Canonge, Nuria Paz Torres Aguila
Funding agency: Instituto de Salud Carlos III
Funding: 836037.4
Reference: PMP15/00022
Duration: 01/01/2016 - 31/12/2019

Diabetis i Metabolisme (GRC)

IP: Rafael Simó Canonge
Collaborators: Josep A Villena Delgado, Carles Zafon Llopis, Cristina Hernández Pascual, David Martinez Selva, Andreea Ciudin Mihai, Lorena Ramos Pérez, Rosa Burgos Peláez, Olga Simó Servat, Patricia Bogdanov Baruj
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2014 SGR 270
Duration: 01/01/2014 - 31/12/2016

European Consortium for Risk stratification and Management of Diabetic Macular Edema (EURODIME). A multidisciplinary approach based on Systems Biology. ECoDIME

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 22500
Reference: EUIN2013-51220
Duration: 01/10/2013 - 30/09/2015

Impacte de la dieta rica en sardina en el control metabòlic de la diabetis tipus 2

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual, Olga Simó Servat
Funding agency: Associació Catalana de Diabetis
Funding: 10000
Reference: GLLV/2013-SIMO
Duration: 31/03/2014 - 31/03/2016

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Andrea Casal Pardo

Andrea Casal Pardo

Predoctoral researcher
Kidney Physiopathology
Read more
Sergi Martí Beltran

Sergi Martí Beltran

Pneumology
Read more
Belén Moro

Belén Moro

P. Management and Admin. Technical specialist
Pre-Award Project Unit
Competitive Research Directorate
Read more
Miriam  Moratal  Cloquell

Miriam Moratal Cloquell

General Surgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.